Spelsberg TC et al. |
The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. |
1999 |
Mol. Endocrinol. |
pmid:10379881
|
Shin J et al. |
Structure-function of the TNF receptor-like cysteine-rich domain of osteoprotegerin. |
2008 |
Mol. Cells |
pmid:18443424
|
Kang HS et al. |
Receptor activator of nuclear factor-kappaB is induced by a rottlerin-sensitive and p38 MAP kinase-dependent pathway during monocyte differentiation. |
2004 |
Mol. Cells |
pmid:15232218
|
Naranjo-Suarez S et al. |
Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. |
2013 |
Mol. Cells |
pmid:23912593
|
Wang Y et al. |
LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. |
2011 |
Mol. Cell. Endocrinol. |
pmid:21291955
|
Olesen M et al. |
No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. |
2012 |
Mol. Cell. Endocrinol. |
pmid:22698523
|
Kühn MC et al. |
Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. |
2012 |
Mol. Cell. Endocrinol. |
pmid:22040599
|
Tsubaki M et al. |
Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. |
2012 |
Mol. Cell. Endocrinol. |
pmid:22579611
|
Welldon KJ et al. |
Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. |
2013 |
Mol. Cell. Endocrinol. |
pmid:23791847
|
Ma Y et al. |
Acetylcholine affects osteocytic MLO-Y4 cells via acetylcholine receptors. |
2014 |
Mol. Cell. Endocrinol. |
pmid:24508663
|
Oostra DR et al. |
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. |
2015 |
Mol. Cell. Endocrinol. |
pmid:25575458
|
Toffoli B et al. |
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. |
2011 |
Mol. Cell. Endocrinol. |
pmid:20832449
|
Gutiérrez-Rojas I et al. |
Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. |
2013 |
Mol. Cell. Endocrinol. |
pmid:23178165
|
Geoffroy V et al. |
High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. |
2002 |
Mol. Cell. Biol. |
pmid:12167715
|
Mizukami J et al. |
Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. |
2002 |
Mol. Cell. Biol. |
pmid:11809792
|
Subramaniam M et al. |
TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. |
2005 |
Mol. Cell. Biol. |
pmid:15657444
|
Yamaguchi M et al. |
Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: enhancement of Runx2, OPG, and regucalcin mRNA expressions. |
2008 |
Mol. Cell. Biochem. |
pmid:18327666
|
Guo D et al. |
Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. |
2012 |
Mol. Cell. Biochem. |
pmid:22167620
|
Osorio A et al. |
Biochemical markers of vascular calcification in elderly hemodialysis patients. |
2013 |
Mol. Cell. Biochem. |
pmid:23124853
|
Rani CS and MacDougall M |
Dental cells express factors that regulate bone resorption. |
2000 |
Mol. Cell Biol. Res. Commun. |
pmid:10860862
|
Locklin RM et al. |
Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis. |
2007 |
Mol. Cancer Ther. |
pmid:18065493
|
Miller RE et al. |
RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis. |
2008 |
Mol. Cancer Ther. |
pmid:18606716
|
Cao Y et al. |
The osterix transcription factor down-regulates interleukin-1 alpha expression in mouse osteosarcoma cells. |
2008 |
Mol. Cancer Res. |
pmid:18234967
|
Higgs JT et al. |
Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. |
2015 |
Mol. Cancer Res. |
pmid:25636966
|
Weichhaus M et al. |
Osteoprotegerin in breast cancer: beyond bone remodeling. |
2015 |
Mol. Cancer |
pmid:26054853
|
Fujita K and Janz S |
Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. |
2007 |
Mol. Cancer |
pmid:17971207
|
Arrigoni C et al. |
Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. |
2014 |
Mol. Cancer |
pmid:25335447
|
Reid PE et al. |
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact. |
2009 |
Mol. Cancer |
pmid:19604388
|
Chung ST et al. |
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. |
2017 |
Mol. Cancer |
pmid:28143606
|
Xiao HL et al. |
Oral administration activity determination of recombinant osteoprotegerin from silkworm larvae. |
2007 |
Mol. Biotechnol. |
pmid:17435284
|
Hussien YM et al. |
Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. |
2013 |
Mol. Biol. Rep. |
pmid:23271131
|
Lee YH et al. |
Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. |
2010 |
Mol. Biol. Rep. |
pmid:19642016
|
Watkins M et al. |
Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. |
2011 |
Mol. Biol. Cell |
pmid:21346198
|
Pritzker LB et al. |
The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. |
2004 |
Mol. Biol. Cell |
pmid:15064358
|
Jung YJ et al. |
Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. |
2017 |
Mol Oral Microbiol |
pmid:27484636
|
Sänger N et al. |
OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. |
2014 |
Mol Oncol |
pmid:24785095
|
Crosley LK et al. |
The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. |
2013 |
Mol Nutr Food Res |
pmid:23934705
|
Nash LA et al. |
Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. |
2015 |
Mol Nutr Food Res |
pmid:25488131
|
Zhou QL et al. |
Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. |
2016 |
Mol Med Rep |
pmid:27357904
|
Li J et al. |
Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. |
2016 |
Mol Med Rep |
pmid:26647856
|
Ren H et al. |
Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. |
2015 |
Mol Med Rep |
pmid:26398911
|
Joo MK et al. |
The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats. |
2013 |
Mol Med Rep |
pmid:23426758
|
Ye M et al. |
Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. |
2015 |
Mol Med Rep |
pmid:26459042
|
Ma Y et al. |
Effects of brucine on bone metabolism in multiple myeloma. |
2012 |
Mol Med Rep |
pmid:22614932
|
Xu F et al. |
Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity. |
2013 |
Mol Med Rep |
pmid:23835909
|
Wei J et al. |
Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. |
2015 |
Mol Med Rep |
pmid:25891179
|
Wang XF et al. |
The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. |
2013 |
Mol Med Rep |
pmid:23440406
|
Kuroyanagi G et al. |
Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. |
2015 |
Mol Med Rep |
pmid:26044505
|
Jia J et al. |
Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. |
2017 |
Mol Med Rep |
pmid:28260003
|
Feng ZY et al. |
Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. |
2013 |
Mol Med Rep |
pmid:24126801
|
Pei Z et al. |
Effect of icariin on cell proliferation and the expression of bone resorption/formation-related markers in human periodontal ligament cells. |
2013 |
Mol Med Rep |
pmid:24065204
|
Kainuma S et al. |
Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. |
2016 |
Mol Med Rep |
pmid:26935864
|
Qian H et al. |
FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. |
2016 |
Mol Med Rep |
pmid:27510616
|
He M et al. |
Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. |
2016 |
Mol Med Rep |
pmid:27277157
|
Zheleznyak A et al. |
Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. |
2012 |
Mol Imaging Biol |
pmid:21853370
|
Wang Y et al. |
A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level. |
2009 |
Mol Cell Biomech |
pmid:19496258
|
Asanuma YF et al. |
Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. |
2013 |
Mod Rheumatol |
pmid:22584471
|
Tanishima S et al. |
Minodronic acid influences receptor activator of nuclear factor kappaB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis. |
2007 |
Mod Rheumatol |
pmid:17564774
|
Mirzaei K et al. |
Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. |
2012 |
Minerva Med. |
pmid:22805623
|
Aydin H et al. |
Effect of oxidative stress on aorta and tibia osteoprotegerin gene expression in ovariectomized rats. |
2011 |
Minerva Endocrinol. |
pmid:21519319
|
Kobayashi-Sakamoto M et al. |
Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation. |
2008 |
Microvasc. Res. |
pmid:18656492
|
Sasaki T |
Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption. |
2003 |
Microsc. Res. Tech. |
pmid:12879416
|
Helfrich MH |
Osteoclast diseases. |
2003 |
Microsc. Res. Tech. |
pmid:12879419
|
Reddi D et al. |
Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells. |
2008 Nov-Dec |
Microbes Infect. |
pmid:18789397
|
Belibasakis GN et al. |
Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. |
2011 |
Microb. Pathog. |
pmid:21075196
|
Belibasakis GN et al. |
Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. |
2007 |
Microb. Pathog. |
pmid:17448630
|
Krause U et al. |
Assays of osteogenic differentiation by cultured human mesenchymal stem cells. |
2011 |
Methods Mol. Biol. |
pmid:21431522
|
Nimmanapalli R and Bhalla K |
Targets in apoptosis signaling: promise of selective anticancer therapy. |
2003 |
Methods Mol. Biol. |
pmid:12777745
|
Oh ES et al. |
Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women. |
2005 |
Metab. Clin. Exp. |
pmid:15562379
|
Nabipour I et al. |
Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. |
2010 |
Metab. Clin. Exp. |
pmid:19922962
|
Ostergård T et al. |
Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training. |
2006 |
Metab. Clin. Exp. |
pmid:17046554
|
O'Sullivan EP et al. |
A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. |
2013 |
Metab. Clin. Exp. |
pmid:22841521
|
Siepi D et al. |
Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. |
2008 |
Metab. Clin. Exp. |
pmid:18249202
|
Maïmoun L et al. |
Peripubertal female athletes in high-impact sports show improved bone mass acquisition and bone geometry. |
2013 |
Metab. Clin. Exp. |
pmid:23490587
|
Ashley DT et al. |
Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. |
2011 |
Metab. Clin. Exp. |
pmid:21087777
|
Wieczorek-Baranowska A et al. |
Osteocalcin and glucose metabolism in postmenopausal women subjected to aerobic training program for 8 weeks. |
2012 |
Metab. Clin. Exp. |
pmid:22000586
|
Takemura M et al. |
Relationship between osteoprotegerin/osteoclastogenesis inhibitory factor concentration in synovial fluid and disease severity in individuals with osteoarthritis of the knee. |
2001 |
Metab. Clin. Exp. |
pmid:11172466
|
Giusti M et al. |
Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study. |
2007 |
Metab. Clin. Exp. |
pmid:17445547
|
Chang YH et al. |
Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. |
2011 |
Metab. Clin. Exp. |
pmid:21251686
|
Ziegler S et al. |
Endurance running acutely raises plasma osteoprotegerin and lowers plasma receptor activator of nuclear factor kappa B ligand. |
2005 |
Metab. Clin. Exp. |
pmid:15988704
|
Nabipour I et al. |
Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. |
2009 Sep-Oct |
Menopause |
pmid:19387415
|
Pineda B et al. |
Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. |
2012 |
Menopause |
pmid:22067277
|
Kim H et al. |
The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women. |
2012 |
Menopause |
pmid:22668815
|
Di Carlo C et al. |
Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women. |
2007 Jan-Feb |
Menopause |
pmid:17075432
|
Lee HJ et al. |
Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. |
2014 |
Menopause |
pmid:23760429
|
Prezelj J et al. |
Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women. |
2008 Mar-Apr |
Menopause |
pmid:17882010
|
Kim JG et al. |
Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women. |
2008 Mar-Apr |
Menopause |
pmid:17925661
|
Kim H et al. |
Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women. |
2011 |
Menopause |
pmid:21471826
|
Uemura H et al. |
Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women. |
2008 Jan-Feb |
Menopause |
pmid:17545921
|
Reyes-GarcÃa R et al. |
Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. |
2010 Jan-Feb |
Menopause |
pmid:19574937
|
Crisafulli A et al. |
Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. |
2005 |
Menopause |
pmid:15772566
|
Tyagi AM et al. |
Formononetin reverses established osteopenia in adult ovariectomized rats. |
2012 |
Menopause |
pmid:22781783
|
Zhang ZG et al. |
Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats. |
2013 |
Menopause |
pmid:23096243
|
McClung MR |
Looking for answers in all the wrong places. |
2007 Jan-Feb |
Menopause |
pmid:17194959
|
Kim JG et al. |
Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. |
2007 Sep-Oct |
Menopause |
pmid:17667143
|
Aubin JE and Bonnelye E |
Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. |
2000 |
Medscape Womens Health |
pmid:10792853
|
Kwon A et al. |
Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. |
2016 |
Medicine (Baltimore) |
pmid:27082605
|
Shen A et al. |
Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. |
2014 |
Medicine (Baltimore) |
pmid:25546658
|
Li Y et al. |
OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. |
2016 |
Medicine (Baltimore) |
pmid:27336899
|
Wang JH et al. |
Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. |
2016 |
Medicine (Baltimore) |
pmid:27310953
|